Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
RESEARCH TOOLSreports
Sunshine Biopharma (SBFM) Stock Price & Analysis
152 Followers
SBFM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.04 - $1.40
Previous Close$0.06
Volume30.82M
Average Volume (3M)16.24M
Market Cap
$6.02M
Enterprise Value-$12.83M
Total Cash (Recent Filing)$18.85M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.3
Beta0.21
Next Earnings
Apr 03, 2024EPS Estimate
-$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding25,678,290
10 Day Avg. Volume5,188,196
30 Day Avg. Volume16,244,604
Standard Deviation4.47
R-Squared0.02
Alpha1.02
Financial Highlights & Ratios
Price to Book (P/B)0.07
Price to Sales (P/S)0.39
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.63
Enterprise Value/Gross Profit-7.56
Enterprise Value/Ebitda4.47
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sunshine Biopharma News
PremiumCompany Announcements
Sunshine Biopharma’s Strong Growth and Optimistic Outlook
PremiumCompany Announcements
Sunshine Biopharma CEO Enacts Key Warrant AmendmentsOwnership Overview
23.68% Insiders
0.31% Mutual Funds
2.43% Other Institutional Investors
73.59% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SBFM FAQ
What was Sunshine Biopharma’s price range in the past 12 months?
Sunshine Biopharma lowest stock price was $0.04 and its highest was $1.40 in the past 12 months.
What is Sunshine Biopharma’s market cap?
Currently, no data Available
When is Sunshine Biopharma’s upcoming earnings report date?
Sunshine Biopharma’s upcoming earnings report date is Apr 03, 2024 which is 31 days ago.
How were Sunshine Biopharma’s earnings last quarter?
Sunshine Biopharma released its earnings results on Nov 13, 2023. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.06 by $0.02.
Is Sunshine Biopharma overvalued?
According to Wall Street analysts Sunshine Biopharma’s price is currently Overvalued.
Does Sunshine Biopharma pay dividends?
Sunshine Biopharma does not currently pay dividends.
What is Sunshine Biopharma’s EPS estimate?
Sunshine Biopharma’s EPS estimate is -$0.03.
How many shares outstanding does Sunshine Biopharma have?
Sunshine Biopharma has 99,452,866 shares outstanding.
What happened to Sunshine Biopharma’s price movement after its last earnings report?
Sunshine Biopharma reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.06. Following the earnings report the stock price went down -13.793%.
Which hedge fund is a major shareholder of Sunshine Biopharma?
Currently, no hedge funds are holding shares in SBFM
---
Sunshine Biopharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $2.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 45.4%
Last 30 Days ▲ 45.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.66%
12-Months-Change
Fundamentals
Return on Equity
-85.87%
Trailing 12-Months
Asset Growth
-32.34%
Trailing 12-Months
Company Description
Sunshine Biopharma
Sunshine Biopharma, Inc. engages in the the research, development and commercialization of drugs for the treatment of various forms of cancer. Its products include Adva-27a, SBI-Anastrozol, SBI-Letrozole, SBI-Bicalutamide, SBI-Finasteride, and Essential 9. The company was founded on August 31, 2006 and is headquartered in Montreal, Canada.
---
SBFM Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering SBFM
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-87.70%
initiated a buy rating 9 months ago
Copying David Bouchey's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -87.70% per trade.
---